Clinical Trial Update: Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tislelizumab plus chemotherapy followed by thoracic consolidation radiotherapy as first-line treatment for extensive-stage s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 2 | Status: RECRUITING